Decision on future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds)

On 3 September 2009, the Danish Medicines Agency decided on the future reimbursement status of medicinal products in ATC group A06 (laxatives) and A02AA04 (magnesium compounds). These medicinal products will still not be eligible for general reimbursement.

In the box, you can find a link to the letter containing the decision which the Danish Medicines Agency has sent to companies which hold a marketing authorisation for products comprised by the decision.

Danish Medicines Agency, 4 September 2009